Thomas J. Schuetz insider trades

Open-market stock purchases and sales by Thomas J. Schuetz, CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc, from SEC Form 4 filings since Jun 19, 2014.

Recent trades

DateStockTradeValue
Feb 8, 2026CMPX Compass Therapeutics, IncSold (not open market)$239K
Jan 9, 2026CMPX Compass Therapeutics, IncSold (not open market)$250K
Jan 2, 2026CMPX Compass Therapeutics, IncBought (not open market)$1.3M
Jan 2, 2026CMPX Compass Therapeutics, IncBought (not open market)—
Nov 16, 2025CMPX Compass Therapeutics, IncSold (not open market)$213K

Companies traded

  • CMPX Compass Therapeutics, Inc: 22 buys, last Feb 8, 2026
  • BOLD Audentes Therapeutics, Inc: other filings, last Jan 15, 2020
  • RLYP Relypsa Inc: 1 buy, 1 sale, last Sep 1, 2016

Get free alerts when Thomas J. Schuetz files a new trade →